J. Liesveld

发表

Hematopoietic growth factors and acute leukemia.

J. Rowe, J. Liesveld, 1999, Cancer treatment and research.

Treatment and prognostic factors in acute myeloid leukaemia.

J. Rowe, J. Liesveld, 1996, Bailliere's clinical haematology.

Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

J. Rowe, M. Lichtman, J. Liesveld, 1987, Blood.

Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors

R. Brasacchio, A. Muhs, S. Eberly, 1998, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide

J. DiPersio, R. Duerst, C. Abboud, 2000, Bone Marrow Transplantation.

Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants

J. Rowe, C. Packman, J. DiPersio, 1999, Bone Marrow Transplantation.

Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant.

J. Rowe, A. Gaspari, R. Burns, 2000, Journal of the American Academy of Dermatology.

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

L. Constine, J. Liesveld, C. Abboud, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

M. A. Tanner, J. Liesveld, C. Abboud, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematopoietic growth factors in acute leukemia

J. Rowe, J. Liesveld, 1997, Leukemia.

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

B. Simonsson, J. Rowe, C. Packman, 1999, Bone Marrow Transplantation.

Handbook of Bone Marrow Transplantation

Jane L. Liesveld, J. Liesveld, 2000 .

Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors

R. Lifton, S. Eberly, J. Rowe, 1997, Bone Marrow Transplantation.

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

J. Dipersio, M. A. Tanner, L. Constine, 1995, Bone marrow transplantation.